中国循证心血管医学杂志2024,Vol.16Issue(4) :433-435.DOI:10.3969/j.issn.1674-4055.2024.04.10

沙库巴曲缬沙坦治疗原发性高血压的可行性分析

Sakubatril-valsartan for treating essential hypertension:a feasibility analysis

熊海亮 胡凤英 黄安静 贾春新 张天铧 张英
中国循证心血管医学杂志2024,Vol.16Issue(4) :433-435.DOI:10.3969/j.issn.1674-4055.2024.04.10

沙库巴曲缬沙坦治疗原发性高血压的可行性分析

Sakubatril-valsartan for treating essential hypertension:a feasibility analysis

熊海亮 1胡凤英 1黄安静 1贾春新 1张天铧 1张英1
扫码查看

作者信息

  • 1. 063000 唐山,唐山中心医院心血管内科
  • 折叠

摘要

目的 探讨沙库巴曲缬沙坦对原发性高血压患者交感神经活性、血管内皮功能的影响.方法 选取2021年7月至2022年6月于唐山中心医院收治的120例高血压患者为研究对象,采用随机数字表法分为对照组与研究组,每组各60例.对照组采用氨氯地平治疗,治疗初始服用剂量5 mg,qd,最大剂量为10 mg.连续服用1周后,根据患者情况调整剂量.研究组在对照组基础上加用沙库巴曲缬沙坦治疗50 mg,bid.对比两组患者血压水平[收缩压(SBP)、舒张压(DBP)]、交感神经活性水平[肾上腺素(E)、肾素活性(PRA)、去甲肾上腺素(NE)、血管紧张素Ⅱ(AngⅡ)]、一氧化氮(NO)、血管内皮素-1(ET-1)以及不良反应发生情况.结果 治疗后,研究组患者SBP、DBP均高于对照组,差异有统计学意义(P<0.05);治疗后两组NE、E、PRA、AngⅡ均降低,研究组水平低于对照组,差异有统计学意义(P<0.05);治疗后,两组患者NO、ET-1均升高,研究组水平高于对照组,差异有统计学意义(P<0.05);两组患者不良反应发生率相比,差异无统计学意义(P>0.05).结论 沙库巴曲缬沙坦应用于原发性高血压患者的治疗疗效显著,可降低交感神经活性、改善血管内皮功能.

Abstract

Objective To discuss the influence of sakubatril-valsartan on sympathetic nerve activity and vascular endothelial function in patients with essential hypertension(EH).Methods EH patients(n=120)were chosen from Tangshan Central Hospital from July 2021 to June 2022,and divided,according to random digital table,into control group and study group(each n=60).The control group was treated with amlodipine,with an initial dose of 5 mg/d,up to a maximum of 10 mg.After one week of continuous administration,the dosage was adjusted based on the patients'conditions.The study group was additionally treated with sakubatril-valsartan,with a dosage of 50 mg twice daily.The levels of blood pressure[systolic blood pressure(SBP),diastolic blood pressure(DBP)],sympathetic nerve activity[epinephrine(E),plasma renin activity(PRA),noradrenalin(NE),angiotensin Ⅱ(Ang Ⅱ)],nitric oxide(NO)and endothelin-1(ET-1),and adverse reactions were compared between 2 groups.Results After treatment,levels of SBP and DBP were higher in study group than those in control group(P<0.05),levels of NE,E,PRA and Ang Ⅱ decreased in 2 groups,and were lower in study group than those in control group(P<0.05),and levels of NO and ET-1 increased,and were higher in study group than those in control group(P<0.05).The difference in incidence of adverse reactions had no statistical significance between 2 groups(P>0.05).Conclusion The curative effect of sakubatril-valsartan is significant in EH patients,which can reduce sympathetic nerve activity and improve vascular endothelial function.

关键词

原发性高血压/沙库巴曲缬沙坦/交感神经活性/血管内皮功能

Key words

Essential hypertension/Sakubatril-valsartan/Sympathetic nerve activity/Vascular endothelial function

引用本文复制引用

基金项目

河北省医学科学研究课题计划(20221849)

出版年

2024
中国循证心血管医学杂志
中国人民解放军北京军区总医院

中国循证心血管医学杂志

CSTPCD
影响因子:1.272
ISSN:1674-4055
段落导航相关论文